These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 21356164

  • 1. The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.
    Yarom N, Jonker DJ.
    Discov Med; 2011 Feb; 11(57):95-105. PubMed ID: 21356164
    [Abstract] [Full Text] [Related]

  • 2. The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer.
    Bouché O, Beretta GD, Alfonso PG, Geissler M.
    Cancer Treat Rev; 2010 Feb; 36 Suppl 1():S1-10. PubMed ID: 20189053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation.
    Giampieri R, Scartozzi M, Del Prete M, Maccaroni E, Bittoni A, Faloppi L, Bianconi M, Cecchini L, Cascinu S.
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):272-83. PubMed ID: 23806981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Perspective of personalized (precise) cancer therapy based on predictive biomarkers].
    Osera S, Yoshino T.
    Nihon Rinsho; 2014 Jan; 72(1):29-34. PubMed ID: 24597345
    [Abstract] [Full Text] [Related]

  • 13. Where now for anti-EGF receptor therapies in colorectal cancer?
    Shaw PH, Adams RA.
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1543-53. PubMed ID: 21999128
    [Abstract] [Full Text] [Related]

  • 14. Targeted treatments in colorectal cancer: state of the art and future perspectives.
    Arnold D, Seufferlein T.
    Gut; 2010 Jun; 59(6):838-58. PubMed ID: 20551469
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor as a therapeutic target in veterinary oncology.
    Bergkvist GT, Yool DA.
    Vet Comp Oncol; 2011 Jun; 9(2):81-94. PubMed ID: 21569194
    [Abstract] [Full Text] [Related]

  • 16. Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.
    Spano JP, Milano G, Vignot S, Khayat D.
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):21-30. PubMed ID: 18206383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [EGF receptors in colorectal cancers].
    Spano JP, Vignot S.
    Bull Cancer; 2007 Apr; 94(7 Suppl):F171-6. PubMed ID: 17964993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.